Option Care Health (NASDAQ:OPCH) Price Target Raised to $35.00

Option Care Health (NASDAQ:OPCH) had its target price hoisted by investment analysts at Bank of America from $32.00 to $35.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Bank of America‘s target price would indicate a potential upside of 8.33% from the company’s previous close.

A number of other research analysts have also recently commented on OPCH. Barrington Research reissued an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Friday, October 31st. JMP Securities set a $36.00 price objective on shares of Option Care Health in a research report on Friday, October 31st. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research report on Friday, October 31st. Cowen began coverage on Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating on the stock. Finally, Deutsche Bank Aktiengesellschaft increased their price target on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday. Ten equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $35.90.

Option Care Health Stock Up 5.6%

Shares of NASDAQ:OPCH traded up $1.72 during mid-day trading on Tuesday, hitting $32.31. 1,351,503 shares of the company traded hands, compared to its average volume of 1,917,783. The firm’s 50 day simple moving average is $28.32 and its 200 day simple moving average is $29.29. The firm has a market cap of $5.13 billion, a P/E ratio of 25.65, a PEG ratio of 2.11 and a beta of 0.79. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. Option Care Health has a 52-week low of $22.29 and a 52-week high of $35.53.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of Option Care Health stock in a transaction on Monday, November 3rd. The shares were bought at an average price of $25.98 per share, with a total value of $987,240.00. Following the acquisition, the director directly owned 413,390 shares in the company, valued at approximately $10,739,872.20. This represents a 10.12% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by insiders.

Institutional Investors Weigh In On Option Care Health

Institutional investors and hedge funds have recently made changes to their positions in the company. USA Financial Formulas acquired a new position in Option Care Health in the second quarter worth $26,000. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Option Care Health by 1,492.9% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock valued at $31,000 after buying an additional 836 shares during the period. Cornerstone Planning Group LLC raised its stake in Option Care Health by 7,621.4% during the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the period. McIlrath & Eck LLC acquired a new stake in Option Care Health during the second quarter worth about $37,000. Finally, Brooklyn Investment Group lifted its holdings in Option Care Health by 186.6% in the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after acquiring an additional 780 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.